Yi‐Fei Dong

1.4k total citations
27 papers, 1.2k citations indexed

About

Yi‐Fei Dong is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Yi‐Fei Dong has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 13 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Molecular Biology. Recurrent topics in Yi‐Fei Dong's work include Renin-Angiotensin System Studies (12 papers), Hormonal Regulation and Hypertension (10 papers) and Nitric Oxide and Endothelin Effects (7 papers). Yi‐Fei Dong is often cited by papers focused on Renin-Angiotensin System Studies (12 papers), Hormonal Regulation and Hypertension (10 papers) and Nitric Oxide and Endothelin Effects (7 papers). Yi‐Fei Dong collaborates with scholars based in Japan, China and United States. Yi‐Fei Dong's co-authors include Keiichiro Kataoka, Shokei Kim‐Mitsuyama, Hisao Ogawa, Yoshiko Tokutomi, Eiichiro Yamamoto, Taishi Nakamura, Shinji Matsuba, Hisato Nako, Masaya Fukuda and Kensuke Toyama and has published in prestigious journals such as PLoS ONE, Stroke and The FASEB Journal.

In The Last Decade

Yi‐Fei Dong

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi‐Fei Dong Japan	20	494	320	281	274	175	27	1.2k
Yoshiko Tokutomi Japan	21	488 1.0×	487 1.5×	392 1.4×	273 1.0×	123 0.7×	34	1.6k
Kensuke Toyama Japan	25	461 0.9×	453 1.4×	307 1.1×	448 1.6×	383 2.2×	57	1.7k
Ming-Sheng Zhou China	21	343 0.7×	277 0.9×	341 1.2×	223 0.8×	60 0.3×	54	1.2k
Keiichiro Kataoka Japan	28	665 1.3×	689 2.2×	432 1.5×	375 1.4×	284 1.6×	45	2.1k
J. J. Rob Hermans Netherlands	17	213 0.4×	351 1.1×	274 1.0×	192 0.7×	140 0.8×	35	1.2k
Mamoru Ohkita Japan	25	428 0.9×	457 1.4×	537 1.9×	205 0.7×	59 0.3×	85	1.8k
Elena M. V. de Cavanagh Argentina	19	448 0.9×	488 1.5×	416 1.5×	249 0.9×	55 0.3×	30	1.4k
Yoshisuke Haruna Japan	17	266 0.5×	441 1.4×	350 1.2×	227 0.8×	49 0.3×	23	1.6k
Christoph Köhler Germany	16	790 1.6×	540 1.7×	737 2.6×	268 1.0×	141 0.8×	30	2.2k
Quan Liu China	16	250 0.5×	549 1.7×	183 0.7×	196 0.7×	58 0.3×	26	1.2k

Countries citing papers authored by Yi‐Fei Dong

Since Specialization

Citations

This map shows the geographic impact of Yi‐Fei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Fei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Fei Dong more than expected).

Fields of papers citing papers by Yi‐Fei Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Fei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Fei Dong. The network helps show where Yi‐Fei Dong may publish in the future.

Co-authorship network of co-authors of Yi‐Fei Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Fei Dong. A scholar is included among the top collaborators of Yi‐Fei Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Fei Dong. Yi‐Fei Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Ning, et al.. (2026). Aldosterone and Impaired Nocturnal Blood Pressure Decline in Primary Aldosteronism. Journal of the American Heart Association. 15(6). e044976–e044976.

Yamamoto, Eiichiro, Keiichiro Kataoka, Yi‐Fei Dong, et al.. (2012). Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats. PLoS ONE. 7(6). e39162–e39162. 6 indexed citations

Sueta, Daisuke, Taishi Nakamura, Yi‐Fei Dong, et al.. (2012). Amlodipine enhances amelioration of vascular insulin resistance, oxidative stress, and metabolic disorders by candesartan in metabolic syndrome rats. American Journal of Hypertension. 25(6). 704–710. 15 indexed citations

Dong, Yi‐Fei, Keiichiro Kataoka, Yoshiko Tokutomi, et al.. (2011). Perindopril, a centrally active angiotensin‐converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. The FASEB Journal. 25(9). 2911–2920. 117 indexed citations

Dong, Yi‐Fei, Keiichiro Kataoka, Yoshiko Tokutomi, et al.. (2011). Beneficial Effects of Combination of Valsartan and Amlodipine on Salt-Induced Brain Injury in Hypertensive Rats. Journal of Pharmacology and Experimental Therapeutics. 339(2). 358–366. 24 indexed citations

Toyama, Kensuke, Taishi Nakamura, Keiichiro Kataoka, et al.. (2011). Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity. Biochemical and Biophysical Research Communications. 410(3). 508–513. 33 indexed citations

Nakamura, Taishi, Masaya Fukuda, Keiichiro Kataoka, et al.. (2011). Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats. Hypertension Research. 34(7). 817–824. 15 indexed citations

Tokutomi, Yoshiko, Keiichiro Kataoka, Eiichiro Yamamoto, et al.. (2011). Vascular responses to 8‐nitro‐cyclic GMP in non‐diabetic and diabetic mice. British Journal of Pharmacology. 162(8). 1884–1893. 7 indexed citations

Nako, Hisato, Keiichiro Kataoka, Nobutaka Koibuchi, et al.. (2011). Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF. Hypertension Research. 35(2). 194–200. 40 indexed citations

10.

Nakamura, Taishi, Keiichiro Kataoka, Yoshiko Tokutomi, et al.. (2011). Novel mechanism of salt-induced glomerular injury. Journal of Hypertension. 29(8). 1528–1535. 9 indexed citations

11.

Yamamoto, Eiichiro, Keiichiro Kataoka, Yi‐Fei Dong, et al.. (2010). Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats. Journal of Hypertension. 28(6). 1321–1329. 36 indexed citations

12.

Yamamoto, Eiichiro, Taishi Nakamura, Keiichiro Kataoka, et al.. (2010). Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation. Biochemical and Biophysical Research Communications. 403(3-4). 258–263. 26 indexed citations

13.

Dong, Yi‐Fei, Lei Liu, Zhong-Fang Lai, et al.. (2010). Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice. Journal of Hypertension. 28(7). 1554–1565. 32 indexed citations

14.

Kataoka, Keiichiro, Yoshiko Tokutomi, Eiichiro Yamamoto, et al.. (2010). Apoptosis signal-regulating kinase 1 deficiency eliminates cardiovascular injuries induced by high-salt diet. Journal of Hypertension. 29(1). 76–84. 19 indexed citations

15.

Fukuda, Masaya, Taishi Nakamura, Keiichiro Kataoka, et al.. (2010). Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice. Journal of Hypertension. 28(2). 340–352. 55 indexed citations

16.

Fukuda, Masaya, Taishi Nakamura, Keiichiro Kataoka, et al.. (2010). Ezetimibe Ameliorates Cardiovascular Complications and Hepatic Steatosis in Obese and Type 2 Diabetic db/db Mice. Journal of Pharmacology and Experimental Therapeutics. 335(1). 70–75. 39 indexed citations

17.

Yamamoto, Eiichiro, Keiichiro Kataoka, Yi‐Fei Dong, et al.. (2009). Aliskiren Enhances the Protective Effects of Valsartan Against Cardiovascular and Renal Injury in Endothelial Nitric Oxide Synthase–Deficient Mice. Hypertension. 54(3). 633–638. 55 indexed citations

18.

Nakamura, Taishi, Eiichiro Yamamoto, Keiichiro Kataoka, et al.. (2007). Pioglitazone Exerts Protective Effects Against Stroke in Stroke-Prone Spontaneously Hypertensive Rats, Independently of Blood Pressure. Stroke. 38(11). 3016–3022. 70 indexed citations

19.

Yamamoto, Eiichiro, Keiichiro Kataoka, Haruo Shintaku, et al.. (2007). Novel Mechanism and Role of Angiotensin II–Induced Vascular Endothelial Injury in Hypertensive Diastolic Heart Failure. Arteriosclerosis Thrombosis and Vascular Biology. 27(12). 2569–2575. 64 indexed citations

20.

Yamamoto, Eiichiro, Takuro Yamashita, Tomoko Tanaka, et al.. (2006). Pravastatin Enhances Beneficial Effects of Olmesartan on Vascular Injury of Salt-Sensitive Hypertensive Rats, via Pleiotropic Effects. Arteriosclerosis Thrombosis and Vascular Biology. 27(3). 556–563. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact